Trademarkia Logo

Canada

C$
Actineer
FORMALIZED

on 12 Jun 2024

Last Applicant/ Owned by

ITM Isotope Technologies Munich SE

Lichtenbergstr. 185748 Garching

DE

Serial Number

2332381 filed on 8th Feb 2024

Actineer

Trademark usage description

chemical substances, chemical materials and chemical preparations for use in the manufacture of medical and/or radiopharmaceutical products; chemical Read More

Vienna Information


24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information


Class [001]
Chemical substances, chemical materials and chemical preparations for use in the manufacture of medical and/or radiopharmaceutical products; chemical raw materials, in particular actinium-225 radiochemical and/or bismuth-213, for the formulation of radiopharmaceutical products.


Classification kind code

12

Class [005]
Radiopharmaceutical diagnostic and/or therapeutic preparations for medical and/or pharmaceutical purposes, in particular radiopharmaceutical preparations for endoradionuclide therapy, brachytherapy, positron emission tomography (PET), single photon emission computed tomography (SPECT), target radionuclide therapy and peptide receptor radionuclide therapy (PRRT); radiopharmaceutical products, in particular actinium-containing and/or bismuth-containing radiopharmaceutical products in GMP [Good Manufacturing Practice] quality; radiopharmaceutical preparations for use in oncology, in particular radiopharmaceuticals containing radioisotopes, in particular actinium-225 and/or bismuth-213; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular actinium-225 and/or bismuth-213 for the treatment of tumour diseases; target radiopharmaceuticals containing a target molecule, in particular a peptide or an antibody, depending on the indication, and a medical radioactive isotope; radiopharmaceuticals containing actinium-225 and/or bismuth-213 and its complexes.


Classification kind code

12

Class [010]
Medical instruments, apparatus and containers for the production of radiopharmaceutical preparations, in particular for the production of actinium-225 and/or bismuth-213 in GMP quality; control, regulation and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular apparatus for the production of a radiotherapeutic or radiodiagnostic substance, in particular for the production of actinium-225 and/or bismuth-213 in GMP quality; radionuclide generator for radiopharmaceutical purpose.


Classification kind code

12

Class [042]
Scientific and technological services and research relating to the use of actinium-225 and/or bismuth-213 or other alpha emitters, in particular medical and pharmacological research services relating to the use of actinium-225 and/or bismuth-213 or other alpha emitters.


Classification kind code

12

Class [044]
Medical services, in particular services relating to radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology, nuclear medicine and brachytherapies including intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and radionuclide therapy, peptide receptor radionuclide therapy (PRRT), personal nuclear medicine and precision oncology; medical services for theranostics in the field of precision oncology.


Classification kind code

12

Mark Details


Serial Number

2332381

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 14th Apr 2025
Notification of Possible Opposition Sent
Submitted for opposition 257
on 13th Jun 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 12th Jun 2024
Created
Submitted for opposition 31
on 12th Jun 2024
Formalized
Submitted for opposition 30
on 8th Feb 2024
Filed
Submitted for opposition 228
on 8th Feb 2024
International Registration